Remove quality-forum-series-main
article thumbnail

Quality Forum Review: Impacting Patient Outcomes Through Pharmacist-Led Virtual Care Model

PQA

The PQA Quality Forum Webinar is a regular, recurring series on healthcare quality topics with a focus on medication use and medication services. It is a forum for educating and engaging with PQA members and quality-focused healthcare professionals. reduction in emergency department visits.

article thumbnail

Post-Brexit medicines regulation must have international scope

pharmaphorum

The key elements to achieve this rely on being patient-focused, innovation-focused, and forward-looking,” said the authors, adding that Britain must remain an “effective player on the main stage”. The industry stands ready to partner with government to ensure the success and international recognition of this agenda.”. Recommendations.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Salesforce in the healthcare industry: capabilities, applications, alternatives

Viseven

A Few Typical Cases For years, Salesforce’s mission in life sciences and healthcare has been the same – to be one of the main drivers for digital transformation and put relationships with organizations at the heart of activity. How is Salesforce Used in Healthcare? Salesforce Healthcare Benefits – Are They Real?

article thumbnail

Sustainability: Corporate Ambition, Governance, & Accelerated Delivery

ISPE

Directors’ Oversight Role Today: Increased Expectations, Responsibility and Accountability—A Macro View, Harvard Law School Forum on Corporate Governance.” antimicrobial resistance), effects of pollution on air quality, and a focus on biodiversity, including preserving and restoring ecosystems. [link] 5 Peter A. Atkins, P. 10 May 2021.

article thumbnail

An Evaluation of Postapproval CMC Change Timelines

ISPE

These long global approval timelines complicate supply chain management by delaying innovations that improve quality assurance and by increasing the potential for supply interruptions and shortages that impact patient access to products. The WHO is driving implementation by BoHs of GRP, which will improve regulatory processes.